Aratana Therapeutics Inc (NASDAQ:PETX)

19.17
Delayed Data
As of Mar 03
 -0.70 / -3.52%
Today’s Change
9.20
Today|||52-Week Range
23.82
+7.58%
Year-to-Date

Today’s Trading

Previous close19.87
Today’s open19.81
Day’s range-- - --
Volume190,378
Average volume (3 months)277,913
Market cap$689.6M
Dividend yield--
Data as of 03/03/2015

Growth & Valuation

Earnings growth (last year)+61.39%
Earnings growth (this year)-251.92%
Earnings growth (next 5 years)-32.79%
Revenue growth (last year)--
P/E ratio191.7
Price/Sales1,717.35
Price/Book5.41

Competitors

 Today’s
change
Today’s
% change
ENTAEnanta Pharmaceutica...+0.18+0.50%
TBPHTheravance Biopharma...+0.23+1.11%
RPTPRaptor Pharmaceutica...-0.07-0.72%
OREXOrexigen Therapeutic...+1.85+31.95%
Data as of 03/03/2015

Financials

Next reporting dateMarch 12, 2015
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$123.0K
Annual profit (last year)-$4.3M
Net profit margin-3,485.37%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Steven St. Peter
Chief Financial Officer &
Treasurer
Craig A. Tooman
Corporate headquarters
Kansas City, Kansas

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account